medroxyprogesterone acetate has been researched along with Uterine Neoplasms in 170 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 89 (52.35) | 18.7374 |
| 1990's | 56 (32.94) | 18.2507 |
| 2000's | 11 (6.47) | 29.6817 |
| 2010's | 12 (7.06) | 24.3611 |
| 2020's | 2 (1.18) | 2.80 |
| Authors | Studies |
|---|---|
| Bertozzi, S; Biasioli, A; Cagnacci, A; Londero, AP; Mangino, FP; Mariuzzi, L; Orsaria, M; Scrimin, F | 1 |
| Lumbiganon, P; Pattanittum, P; Sangkomkamhang, US | 1 |
| Chiang, W; Hsia, SM; Lin, PH; Shih, CK; Yen, YT | 1 |
| Laopaiboon, M; Lumbiganon, P; Mol, BW; Sangkomkamhang, US | 1 |
| Iwazaki, M; Masuda, R; Nakamura, Y; Nakano, M; Sato, T; Shimada, A | 1 |
| McLaren, JS; Morris, EP; Rymer, J; Simpson, PD | 1 |
| Martínez-Uribe, A; Olvera-Maldonado, AJ; Rendón-Macías, ME; Sangines-Martínez, A | 1 |
| Kanao, H; Kondo, E; Matoda, M; Nomura, H; Sugiyama, Y; Takeshima, N; Tanigawa, T | 1 |
| Britten, J; Catherino, WH; Cox, J; Malik, M; Patel, A | 1 |
| Abraham, T; Arian, SE; Bartels, CB; Cayton, KC; Chuong, FS; Holthouser, K; Segars, JH | 1 |
| Baird, DD; Davis, B; Garrett, TA; Laughlin, SK; Peddada, SD; Semelka, RC | 1 |
| Bae, JH; Kim, DC; Lee, SJ; Namkoong, SE; Park, JS | 1 |
| Kim, JY; Park, CT; Park, H; Seok, JM; Seong, SJ; Shim, JY; Yoon, BS | 1 |
| Mizuno, M; Nakanishi, T; Nawa, A; Yatabe, Y | 1 |
| ANDERSON, DG | 1 |
| Adams-Huet, B; Bradshaw, KD; Breslau, NA; Carr, BR; Peng, N; Steinkampf, MP | 1 |
| Fletcher, H; Johnson, N; Reid, M | 1 |
| Bagratee, JS; Moodley, J; Venkatachalam, S | 1 |
| Honma, H; Komura, H; Mizutani, T; Nakamuro, K; Sugihara, A; Terada, N | 1 |
| Dörken, B; Kretzschmar, A; Lindner, T; Mrozek, A; Pink, D; Reichardt, P; Thuss-Patience, PC | 1 |
| Hasegawa, K; Komiyama, S; Nishio, E; Udagawa, Y; Yasue, A | 1 |
| Amato, G; Capuano, F; Carella, C; Figlia, A; Papaleo, C; Zito, GA | 1 |
| Titova, NP; Titova, VA | 1 |
| Kaiser, R; Schulz, KD | 1 |
| de la Pena, MM; Deligdisch, L; Deppe, G; Fleming, H; Gurpide, E; Holinka, CF; Namit, C | 1 |
| Billiet, G; Bonte, J; De Hertogh, R; Ide, P; Vlaemynck, G | 1 |
| Grönroos, M; Kauppila, A; Nieminen, U | 1 |
| Boyd, NR; Moazzami, B; Van der Walt, JD | 1 |
| Hatcher, RA; Maine, D; Rochat, R; Rosenfield, A; Shelton, J | 1 |
| Hocke, M; Röttger, P; Stertmann, WA | 1 |
| Fraser, IS | 1 |
| Crona, N; Enk, L; Samsioe, G; Silfverstolpe, G; Skryten, A | 1 |
| Allegra, JC; Carlson, JA; Day, TG; Wittliff, JL | 1 |
| Donadio, C; Fabri, M; Mazzoni, P; Nazzicone, P; Rendina, GM | 1 |
| Crona, N; Enk, L; Friberg, LG; Samsioe, G; Silfverstolpe, G | 2 |
| Eskola, J; Grönroos, M | 1 |
| Kauppila, A | 1 |
| Szarvas, Z; Zsolnai, B | 2 |
| Gitsch, E; Salzer, H | 1 |
| Castaneda, TA; Gambrell, RD; Massey, FM; Ricci, CA; Ugenas, AJ; Wright, JM | 1 |
| Minkin, S | 1 |
| Ninagawa, T; Ohta, M; Takeda, A; Tomoda, Y | 1 |
| Nagasaka, T | 1 |
| Cleary, RE; Ehrlich, CE; Young, PC | 1 |
| Kauppila, A; Vihko, R | 1 |
| McGoldrick, IA | 1 |
| Jestila, KJ; Scialli, AR | 1 |
| Ishimaru, T; Masuzaki, H; Samejima, T | 1 |
| Fujimaki, T; Kurabayashi, T; Oda, K; Tanaka, K; Yamamoto, Y; Yasuda, M | 1 |
| Kida, H; Minaguchi, H; Saji, M; Sakakibara, H; Taga, M | 1 |
| McCartney, AJ; Williams, K; Woolas, RP | 1 |
| Sugimura, M; Terao, T | 1 |
| Andersen, J; Barbieri, RL; Brink, PR; Chumas, JC; Eng, CL; Grine, E; Zhao, K | 1 |
| Kanoh, H; Okudaira, Y | 1 |
| Colacurci, N; De Placido, G; Locci, M; Montemagno, U; Zullo, F | 1 |
| Cohen, JD; Robins, HI | 1 |
| Bradshaw, KD; Breslau, NA; Byrd, W; Carr, BR; Marshburn, PB; Roark, M; Steinkampf, MP; Weatherall, PT | 1 |
| Heineman, MJ; Ubachs, JM | 1 |
| Doğu, N; Ekici, E; Gökmen, O; Ozmen, S; Seçkin, NC; Sener, AB | 1 |
| Chegini, N; Dou, Q; Kipersztok, S; Rong, H; Williams, RS | 1 |
| Bäckström, AC; Granberg, S; Hirsjärvi-Lahti, T; Ylöstalo, P | 1 |
| Laopaiboon, M; Lumbiganon, P; Phandhu-fung, S; Rugpao, S; Vudhikamraksa, N; Werawatakul, Y | 1 |
| Thomas, EJ | 1 |
| Kato, J; Kojima, H; Murakami, H; Nakakawaji, K; Sakamoto, J; Uchida, T; Yasue, M | 1 |
| Ikomi, AA; Singer, A | 1 |
| Caird, LE; Gow, SM; Hannan, WJ; Lumsden, MA; West, CP | 1 |
| Bassaw, K; Gangar, K | 1 |
| Bamberger, AM; Erdmann, I; Jenatschke, S; Schulte, HM | 1 |
| Koyama, T; Mori, T; Sakamoto, S; Sassa, S; Shinoda, H | 1 |
| Altieri, P; de Aloysio, D; Penacchioni, P; Salgarello, M; Ventura, V | 1 |
| Hill, DA | 1 |
| Boubli, L | 1 |
| D'Altorio, C; Di Biase, S; Lanzilotti, G; Orsini, G; Pinto, V | 1 |
| Colleoni, R; Nappi, RE; Polatti, F; Viazzo, F | 1 |
| Ichikawa, Y; Yoshikawa, H | 1 |
| Mastrantonio, P; Morelli, M; Noia, R; Palomba, S; Sena, T; Zullo, F | 1 |
| Fujiwara, H; Kosuge, S; Ohwada, M; Sato, I; Shibahara, H; Suzuki, M; Takamizawa, S; Usui, R | 1 |
| Diedrich, K; Naether, O | 1 |
| Angioli, R; Averette, HE; Donato, D; Nguyen, HN; Penalver, M; Perras, J; Ramos, R; Sevin, BU; Voigt, W | 1 |
| Denisov, LE; Odintsov, SV; Vinogradova, NN | 1 |
| Baird, DT; Lumsden, MA; West, CP | 1 |
| Baird, DT; Hillier, H; Lumsden, MA; Sweeting, V; West, CP | 1 |
| Ishizaki, T; Itoh, R; Okada, H; Yamamoto, T; Yasuda, J | 1 |
| Stone, R | 1 |
| Blanchet, P; Friede, J; Lemay, A; Maheux, R; Pratt, X | 1 |
| Asmar, P; Paulson, JD; Saffan, DS | 1 |
| Averette, HE; Donato, D; Nguyen, HN; Penalver, M; Perras, J; Ramos, R; Sevin, BU | 1 |
| Anzai, Y; Ballejo, G; Gong, Y; Gurpide, E; Holinka, CF; Murphy, LC; Murphy, LJ | 1 |
| Haney, AF; Lessey, BA; McCarty, KS; Metzger, DA; Soper, JT | 1 |
| Brooks, PG; Serden, SP | 1 |
| Kato, Y; Kuramoto, H; Morisawa, T | 1 |
| Benedetti, MS; Efthymiopoulos, C; Etienne, MC; Frenay, M; Hurteloup, P; Milano, G; Montcuquet, P; Namer, M; René, N; Vo Van, ML | 1 |
| Abbondante, G; Aleandri, V; Benagiano, G; Elkind-Hirsch, K; Morini, A; Piccinno, F; Primiero, FM | 1 |
| Barbieri, RL | 1 |
| Ikeda, T; Kaneko, M; Mori, N | 1 |
| Geyer, H; Kleine, W; Maier, T; Pfleiderer, A | 1 |
| Fujibayashi, H; Fujimoto, Y; Kitagawa, I; Ohno, Y; Okada, H | 1 |
| Benedetto, MT; Bongiorno, M; De Cicco Nardone, F; Dell'Acqua, S; Iacobelli, S; Margariti, PA; Rossiello, F | 1 |
| Okada, H; Yamamoto, T | 1 |
| King, RJ; Lane, G; Whitehead, MI | 1 |
| Fukushima, M; Hirayama, J; Kubo, K; Sekiguchi, M; Takeda, M | 1 |
| Breitenecker, G; Czerwenka, K; Kucera, H; Salzer, H; Sevelda, P; Vavra, N | 1 |
| Thurzó, L | 1 |
| Titova, VA; Voznyĭ, EK | 1 |
| Adlercreutz, H; Kärkkäinen, J; Nieminen, U; Stenman, UH; Vesterinen, E; Widholm, O | 1 |
| Altaras, MM; Bloch, B; Cloete, K; Goldberg, GL; Wiswedel, K | 1 |
| Hando, T; Kurose, T; Motizuki, M; Ohmori, M; Sasagawa, M; Sasaki, T; Tanaka, K; Yamazaki, T; Yasuda, M | 1 |
| Honjo, H; Naitoh, K; Okada, H; Urabe, M; Yamamoto, T | 1 |
| Fujimoto, J; Fujita, H; Hosoda, S; Okada, H; Tanaka, NG | 1 |
| Okamura, S; Okazaki, T; Sugimoto, O; Ueki, M; Yanagawa, Y | 1 |
| Fujimori, Y; Hata, T; Hirano, M; Ikeda, S; Okada, T; Tajima, H; Tomioka, Y; Yoshida, T | 1 |
| Honjo, H; Kitawaki, J; Okada, H; Urabe, M; Yamamoto, T | 1 |
| Feng, YJ; Zhang, XY | 1 |
| Atkinson, EN; Freedman, RS; Scott, W; Tatman, JL | 1 |
| Fujimoto, J; Fujita, H; Hosoda, S; Okada, H | 1 |
| Hosono, T; Kanoh, H; Matsui, Y; Okudaira, Y | 1 |
| Berman, ML; DiSaia, PJ; Mannel, RS; Rettenmaier, MA; Stratton, JA | 1 |
| Friedman, AJ | 1 |
| Manart, FD; Montag, TW | 1 |
| Bobrov, IuF; Bokhman, IaV; Fel'dkoren, BI; Tsyrlina, EV; Vishnevskiĭ, AS | 1 |
| Bush, TL; Ernster, VL; Huggins, GR; Hulka, BS; Kelsey, JL; Schottenfeld, D | 1 |
| Balogh, I; Patai, K; Szarvas, Z | 1 |
| Gimes, G; Hidvégi, J; Szarvas, Z; Zsolnai, B | 2 |
| Elder, MG; Philipson, KA; White, JO | 1 |
| Bonte, J; Ide, P; Janssens, JP | 1 |
| Decensi, A; Pavesi, L; Prada, GA; Preti, P; Robustelli della Cuna, G; Zanon, P | 1 |
| Gravanis, A; Gurpide, E | 1 |
| Amalfitano, TG; Chumas, JC; Mann, WJ; Mazella, J; Stone, ML; Sun, B; Tseng, JK; Tseng, L; Wallach, RC | 1 |
| Isotalo, HE; Kauppila, AJ; Kivinen, ST; Vihko, RK | 1 |
| MacLaughlin, DT; Richardson, GS | 1 |
| Barter, JF; Hatch, KD; Orr, JW; Shingleton, HM | 1 |
| Falkay, G; Sas, M; Thurzó, L | 1 |
| Griesinger, R; Schindler, AE | 1 |
| Atkinson, EN; Freedman, RS; Jones, LA; Kline, RC | 1 |
| Cremer, P; Kuhn, W; Nagel, GA; Seidel, D; Teichmann, AT; Wander, HE; Wieland, H | 1 |
| Erkkola, R; Grenman, S; Grönroos, M; Kangas, L; Mäenpää, J; Paul, R | 1 |
| Matsumoto, K; Noguchi, S | 1 |
| Fujimoto, J; Fujita, H; Nakata, Y; Okada, H | 1 |
| Kitawaki, J | 1 |
| Clarke, CL; Mortel, R; Satyaswaroop, PG; Zaino, R | 1 |
| Barbieri, RL; Doubilet, PM; Fine, C; Friedman, AJ; Schiff, I | 1 |
| Macdonald, RR; Mason, MK; Thorogood, J | 1 |
| Kozuka, Y; Murata, K; Sugiyama, Y; Taniguchi, H; Toyoda, N; Uematsu, A; Yamamoto, T | 1 |
| Alford, WM; Ehrlich, CE; Stehman, FB; Sutton, GP; Young, PC | 1 |
| Carey, TE; England, BG; Grenman, SE; Grönroos, M; Roberts, JA | 1 |
| Okada, H | 1 |
| Ikegami, H; Inoue, M; Matsumoto, K; Shimizu, I; Tanizawa, O; Terakawa, N | 1 |
| Croxtall, JD; Elder, MG; White, JO | 1 |
| Audet-Lapointe, P; Ayoub, J; Beaulieu, R; Chemaly, R; Cormier, A; Déry, JP; Drouin, P; Gauthier, P; Hanley, J; Méthot, Y | 1 |
| Pronin, VN; Pukhlikov, AV | 1 |
| Lahousen, M; Pickel, H | 1 |
| Aoki, M; Ishida, M; Nagasawa, H; Sakagami, N | 1 |
| Arakawa, O; Hirohashi, T; Obata, N; Ono, M; Sato, Y; Takeuchi, S; Tanaka, K | 1 |
| Dallenbach-Hellweg, G | 1 |
| Bell, SC; Davidson, AC; MacVicar, J; Waites, GT; Walker, RA; Wood, PL | 1 |
| Contreras Ortiz, O; Sananes, CE | 1 |
| Egarter, C; Eppel, W; Husslein, P; Salzer, H; Spona, J | 1 |
| Barnhill, D; Dames, J; Gallup, D; Heller, P; Hoskins, W; Park, R | 1 |
| Grönroos, M; Hietanen, E; Lehtonen, A; Mäntylä, M; Marniemi, J; Niskanen, J; Peltonen, P; Rautio, A | 1 |
| Isotalo, H; Kauppila, A; Kivinen, S; Stenbäck, F; Vihko, R | 1 |
| Cauchi, M; Fortune, D; Quinn, MA | 1 |
| Mortel, R; Satyaswaroop, PG; Whitney, CW | 1 |
| Izutsu, T; Kagabu, T; Kurokawa, Y; Nishiya, I; Satoh, K; Yoshizumi, N | 1 |
| Matsui, Y; Okudaira, Y; Sawada, M | 1 |
19 review(s) available for medroxyprogesterone acetate and Uterine Neoplasms
| Article | Year |
|---|---|
Atypical polypoid adenomyoma follow-up and management: Systematic review of case reports and series and meta-analysis.
Topics: Adenomyoma; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Conservative Treatment; Curettage; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysteroscopy; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Pregnancy; Pregnancy Rate; Uterine Neoplasms | 2020 |
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
Topics: Adult; Antineoplastic Agents, Hormonal; Bias; Contraceptives, Oral; Desogestrel; Female; Goserelin; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Nandrolone; Norethindrone Acetate; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2020 |
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.
Topics: Antineoplastic Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2013 |
Minimising menopausal side effects whilst treating endometriosis and fibroids.
Topics: Antineoplastic Agents, Hormonal; Bone Density; Contraceptives, Oral, Combined; Delayed-Action Preparations; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Receptors, LHRH; Uterine Neoplasms | 2015 |
An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review.
Topics: Androgens; Aromatase Inhibitors; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Curcumin; Delayed-Action Preparations; Drugs, Chinese Herbal; Estradiol; Estrenes; Estrogen Receptor Antagonists; Evidence-Based Medicine; Female; Fulvestrant; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Neoadjuvant Therapy; Norpregnadienes; Oximes; Plant Extracts; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tea; Uterine Myomectomy; Uterine Neoplasms; Vitamin D; Vitamins | 2016 |
[Anti-steroid hormones for uterine cancer].
Topics: Antineoplastic Agents, Hormonal; Estrogen Antagonists; Female; Humans; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Tamoxifen; Uterine Neoplasms | 2008 |
Long acting injectable hormonal contraceptives.
Topics: Animals; Breast Neoplasms; Contraceptive Agents; Delayed-Action Preparations; Dogs; Drug Administration Schedule; Female; Fetus; Humans; Infertility, Female; Infusions, Parenteral; Lactation; Macaca mulatta; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Norethindrone Acetate; Pregnancy; Time Factors; Uterine Neoplasms | 1982 |
Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Forecasting; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Neoplasm Recurrence, Local; Ovarian Neoplasms; Progestins; Receptors, Steroid; Uterine Neoplasms | 1984 |
Depo provera in perspective.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Contraceptive Agents, Female; Dogs; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Pregnancy; Uterine Cervical Dysplasia; Uterine Neoplasms | 1981 |
[Antiestrogen therapy of patients with uterine cancer].
Topics: Danazol; Estrogen Antagonists; Female; Humans; Medroxyprogesterone Acetate; Tamoxifen; Uterine Neoplasms | 1994 |
[Hormonal therapy in endometrial cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Medroxyprogesterone Acetate; Tamoxifen; Thrombosis; Uterine Neoplasms | 1993 |
[Drug treatment of uterine fibromas].
Topics: Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Progestins; Uterine Neoplasms | 1999 |
[Minimally invasive treatment of gynecologic cancers].
Topics: Antineoplastic Agents, Hormonal; Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone Acetate; Minimally Invasive Surgical Procedures; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms | 2001 |
Goserelin (Zoladex) in the treatment of fibroids.
Topics: Buserelin; Combined Modality Therapy; Drug Therapy, Combination; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estradiol; Tamoxifen; Uterine Neoplasms | 1992 |
[Therapy of advanced endometrial cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Prognosis; Uterine Neoplasms | 1990 |
[Growth of endometrial cancer and hormone].
Topics: Aged; Antineoplastic Agents; Chemical Phenomena; Chemistry; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Progesterone; Thrombosis; Uterine Neoplasms | 1989 |
Benefits and risks of menopausal estrogen and/or progestin hormone use.
Topics: Breast Neoplasms; Coronary Disease; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Osteoporosis; Progesterone Congeners; Risk Factors; Uterine Neoplasms | 1988 |
An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer.
Topics: Administration, Oral; Carcinoma, Renal Cell; Clinical Trials as Topic; Diethylstilbestrol; Female; Humans; Injections, Intramuscular; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Prostatic Neoplasms; Uterine Neoplasms | 1986 |
[Conservative organ-preserving measures in precancerous stages of endometrial cancer].
Topics: Adult; Endometrial Hyperplasia; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Precancerous Conditions; Uterine Neoplasms | 1988 |
29 trial(s) available for medroxyprogesterone acetate and Uterine Neoplasms
| Article | Year |
|---|---|
[Medical treatment of the uterine miomas in perimenopausal patients].
Topics: Antineoplastic Agents, Hormonal; Female; Humans; Hysterectomy; Leiomyoma; Longitudinal Studies; Medroxyprogesterone Acetate; Middle Aged; Perimenopause; Prospective Studies; Treatment Outcome; Uterine Neoplasms | 2015 |
Effect of gonadotropin-releasing hormone agonist and medroxyprogesterone acetate on calcium metabolism: a prospective, randomized, double-blind, placebo-controlled, crossover trial.
Topics: Adult; Bone Density; Calcium; Cross-Over Studies; Double-Blind Method; Endometriosis; Female; Gonadotropin-Releasing Hormone; Homeostasis; Humans; Leiomyomatosis; Leuprolide; Medroxyprogesterone Acetate; Placebos; Uterine Neoplasms | 2003 |
Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.
Topics: Adult; Antineoplastic Agents, Hormonal; Cell Proliferation; Drug Administration Schedule; Estrogens, Conjugated (USP); Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Leiomyoma; Leuprolide; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Treatment Outcome; Uterine Neoplasms | 2005 |
Tamoxifen and medroxyprogesterone therapy for advanced endometrial carcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Prognosis; Tamoxifen; Uterine Neoplasms | 1984 |
Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri.
Topics: Adult; Double-Blind Method; Female; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms | 1995 |
GnRHa and steroid add-back therapy for uterine myoma.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Time Factors; Uterine Neoplasms | 1995 |
An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
Topics: Adult; Double-Blind Method; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Luteinizing Hormone; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Middle Aged; Placebos; Prospective Studies; Triptorelin Pamoate; Uterine Neoplasms | 1993 |
The effects of hormone replacement therapy on uterine fibroids in postmenopausal women.
Topics: Antineoplastic Agents, Hormonal; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Postmenopause; Uterine Neoplasms | 1996 |
Uterine findings by transvaginal sonography during percutaneous estrogen treatment in postmenopausal women.
Topics: Case-Control Studies; Drug Administration Schedule; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Time Factors; Ultrasonography; Uterine Neoplasms; Uterus | 1996 |
Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case--control study.
Topics: Adult; Aged; Case-Control Studies; Contraceptive Agents, Female; Female; Humans; Leiomyomatosis; Medroxyprogesterone Acetate; Middle Aged; Reproductive History; Risk Factors; Socioeconomic Factors; Thailand; Uterine Neoplasms | 1996 |
Add-back therapy for long-term use in dysfunctional uterine bleeding and uterine fibroids.
Topics: Adult; Climacteric; Drug Combinations; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Goserelin; Headache; Humans; Leiomyomatosis; Medroxyprogesterone Acetate; Menorrhagia; Middle Aged; Norgestrel; Progestins; Treatment Outcome; Uterine Neoplasms | 1996 |
Medroxyprogesterone acetate with Zoladex for long-term treatment of fibroids: effects on bone density and patient acceptability.
Topics: Adult; Amino Acids; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Density; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms; Uterus | 1997 |
Bleeding patterns in recent postmenopausal outpatients with uterine myomas: comparison between two regimens of HRT.
Topics: Anabolic Agents; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Norpregnenes; Prospective Studies; Uterine Neoplasms | 1998 |
[The effects of menopausal replacement therapy in women with uterine myomas].
Topics: Antineoplastic Agents, Hormonal; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norpregnenes; Time Factors; Uterine Neoplasms | 1999 |
Uterine myoma in postmenopause: a comparison between two therapeutic schedules of HRT.
Topics: Administration, Cutaneous; Administration, Oral; Cyproterone Acetate; Drug Administration Schedule; Estradiol; Female; Hormone Replacement Therapy; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Prospective Studies; Ultrasonography; Uterine Neoplasms | 2000 |
Effect of different doses of progestin on uterine leiomyomas in postmenopausal women.
Topics: Amenorrhea; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Postmenopause; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms | 2002 |
Potential role for medroxyprogesterone acetate as an adjunct to goserelin (Zoladex) in the medical management of uterine fibroids.
Topics: Adult; Buserelin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Uterine Neoplasms | 1992 |
Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Topics: Adult; Case-Control Studies; Confounding Factors, Epidemiologic; Contraceptive Agents, Female; Delayed-Action Preparations; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Risk Factors; Thailand; Uterine Neoplasms | 1991 |
Improved bioavailability of a new oral preparation of medroxyprogesterone acetate.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Antineoplastic Agents; Biological Availability; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms | 1991 |
Sequential Gn-RH superagonist and medroxyprogesterone acetate treatment of uterine leiomyomata.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Delayed-Action Preparations; Female; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Time Factors; Ultrasonography; Uterine Neoplasms | 1990 |
[Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
Topics: Adult; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Tamoxifen; Uterine Neoplasms | 1990 |
[Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
Topics: Adenocarcinoma; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1990 |
An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer.
Topics: Administration, Oral; Carcinoma, Renal Cell; Clinical Trials as Topic; Diethylstilbestrol; Female; Humans; Injections, Intramuscular; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Prostatic Neoplasms; Uterine Neoplasms | 1986 |
Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Tamoxifen; Uterine Neoplasms | 1987 |
Medroxyprogesterone acetate and lipid metabolic changes.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Breast Neoplasms; Cholesterol; Endometriosis; Female; Humans; Lipid Metabolism; Lipids; Lipoproteins; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Triglycerides; Uterine Neoplasms | 1987 |
A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri.
Topics: Adult; Antineoplastic Agents; Cholesterol; Double-Blind Method; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Random Allocation; Uterine Neoplasms | 1988 |
A randomized trial of progestogens in the primary treatment of endometrial carcinoma.
Topics: Aged; Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Fallopian Tubes; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovariectomy; Random Allocation; Uterine Neoplasms | 1988 |
Efficacy of sequential cyclical hormonal therapy in endometrial cancer and its correlation with steroid hormone receptor status.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Prospective Studies; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Remission Induction; Tamoxifen; Uterine Neoplasms | 1988 |
[The medroxyprogesterone acetate serum level following various medroxyprogesterone acetate dose schedules in gynecologic oncology].
Topics: Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Random Allocation; Uterine Neoplasms | 1988 |
123 other study(ies) available for medroxyprogesterone acetate and Uterine Neoplasms
| Article | Year |
|---|---|
Adlay (
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Coix; Diethylstilbestrol; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Mice; Phosphorylation; Plant Extracts; Rats; Uterine Neoplasms | 2019 |
Lobectomy of pulmonary metastasis of endometrial stromal sarcoma.
Topics: Adnexa Uteri; Chemoradiotherapy, Adjuvant; Dysostoses; Female; Humans; Hysterectomy; Lung Neoplasms; Lymph Node Excision; Medroxyprogesterone Acetate; Middle Aged; Pelvis; Pneumonectomy; Sarcoma, Endometrial Stromal; Thorax; Treatment Outcome; Uterine Neoplasms | 2013 |
Long-term outcomes of fertility-sparing treatment of atypical polypoid adenomyoma with medroxyprogesterone acetate.
Topics: Adenomyoma; Adult; Aged; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Fertility Preservation; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Rate; Prognosis; Remission Induction; Retrospective Studies; Time Factors; Uterine Neoplasms | 2016 |
Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
Topics: Antineoplastic Agents, Hormonal; Cell Culture Techniques; Cell Line, Tumor; Collagen Type I; Estradiol; Extracellular Matrix; Female; Fibronectins; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone Acetate; Time Factors; Uterine Neoplasms; Versicans | 2016 |
Short-term change in growth of uterine leiomyoma: tumor growth spurts.
Topics: Adult; Black People; Cell Division; Disease Progression; Estrogens, Conjugated (USP); Female; Humans; Leiomyoma; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Middle Aged; Prevalence; Uterine Neoplasms; Uterus; White People | 2011 |
Oral progesterone treatment in a young woman with müllerian adenosarcoma whose ovary was preserved: a case report.
Topics: Adenosarcoma; Administration, Oral; Adult; Antineoplastic Agents, Hormonal; Female; Humans; Hysterectomy; Hysteroscopy; Medroxyprogesterone Acetate; Mixed Tumor, Mullerian; Ovary; Pregnancy; Pregnancy Complications, Neoplastic; Treatment Outcome; Uterine Neoplasms | 2010 |
Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Contraceptives, Oral, Hormonal; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Maintenance Chemotherapy; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Retrospective Studies; Time Factors; Uterine Neoplasms; Young Adult | 2012 |
Long-term medroxyprogesterone acetate therapy for low-grade endometrial stromal sarcoma.
Topics: Adult; Antineoplastic Agents, Hormonal; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Recurrence; Sarcoma, Endometrial Stromal; Survival Analysis; Uterine Neoplasms | 2012 |
MANAGEMENT OF ADVANCED ENDOMETRIAL ADENOCARCINOMA WITH MEDROXYPROGESTERONE ACETATE.
Topics: Adenocarcinoma; Disease Management; Female; Geriatrics; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Palliative Care; Uterine Neoplasms | 1965 |
[Estrogen plus gestagen especially risky. Breast cancer risk doubled].
Topics: Breast Neoplasms; Controlled Clinical Trials as Topic; Estrogen Replacement Therapy; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Ovarian Neoplasms; Placebos; Risk; Time Factors; Uterine Neoplasms | 2003 |
Depo medroxyprogesterone acetate (DMPA) therapy for uterine myomata prior to surgery.
Topics: Adult; Antineoplastic Agents, Hormonal; Dose-Response Relationship, Drug; Female; Hemoglobins; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menorrhagia; Middle Aged; Preoperative Care; Retrospective Studies; Uterine Neoplasms | 2004 |
Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study.
Topics: Adult; Female; Hemoglobins; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menorrhagia; Pilot Projects; Premenopause; Treatment Outcome; Ultrasonography; Uterine Neoplasms | 2004 |
Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Endometrial Stromal Tumors; Estrogen Replacement Therapy; Female; Humans; Letrozole; Medroxyprogesterone Acetate; Middle Aged; Nitriles; Pelvic Neoplasms; Peritoneal Neoplasms; Retrospective Studies; Tamoxifen; Triazoles; Uterine Neoplasms | 2006 |
ACTH and cortisol plasma levels in cancer patients treated with medroxyprogesterone acetate at high dosages.
Topics: Adrenocorticotropic Hormone; Adult; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Hydrocortisone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Uterine Neoplasms | 1984 |
[Clinical and cytological characteristics of endometrial cancer under radiation therapy].
Topics: Aged; Brachytherapy; Female; Follow-Up Studies; Glucocorticoids; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Radioisotope Teletherapy; Radiotherapy Dosage; Uterine Neoplasms | 1981 |
[Current status of drug treatment of endometrial carcinoma].
Topics: Aminoglutethimide; Antineoplastic Agents; Estrogen Antagonists; Female; Humans; Immunotherapy; Medroxyprogesterone; Medroxyprogesterone Acetate; Palliative Care; Patient Care Planning; Uterine Neoplasms | 1983 |
Evaluation of in vivo and in vitro responses of endometrial adenocarcinoma to progestins.
Topics: Adenocarcinoma; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Progestins; Receptors, Progesterone; Uterine Neoplasms | 1981 |
Estrogen receptors in human uterine adenocarcinoma: correlation with tissue differentiation, vaginal karyopycnotic index, and effect of progestogen or anti-estrogen treatment.
Topics: Adenocarcinoma; Cell Nucleus; Cytosol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Tamoxifen; Uterine Neoplasms; Vagina | 1982 |
Clinical outcome in endometrial cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms | 1982 |
Use of progestogens as an adjuvant to surgery in the treatment of stage I adenocarcinoma of the uterine corpus.
Topics: Adenocarcinoma; Adult; Aged; Castration; Female; Gestonorone Caproate; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Postoperative Period; Recurrence; Uterine Neoplasms | 1983 |
The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
Topics: Delayed-Action Preparations; Developing Countries; Drug Evaluation; Endometriosis; Family Planning Services; Female; Humans; Injections; Legislation, Drug; Medroxyprogesterone; Medroxyprogesterone Acetate; Risk; United States; Uterine Neoplasms; World Health Organization | 1983 |
Long-acting progestins--promise and prospects.
Topics: Animals; Bibliographies as Topic; Breast Neoplasms; Contraceptives, Oral, Combined; Delayed-Action Preparations; Dogs; Female; Haplorhini; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Progesterone Congeners; Rats; Reproduction; Uterine Neoplasms | 1983 |
[Clinovir treatment of adenocarcinoma of the uterus with lung metastases].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Uterine Neoplasms | 1983 |
High-dose depot-medroxyprogesterone acetate (DMPA) - effects on lipid and lipoprotein metabolism.
Topics: Aged; Antineoplastic Agents; Cholesterol; Female; Humans; Lipid Metabolism; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Phospholipids; Triglycerides; Uterine Neoplasms | 1983 |
Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia.
Topics: Adenocarcinoma; Adult; Aged; Cytosol; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms | 1984 |
Changes in apolipoprotein AI after treatment with high-dose medroxyprogesterone acetate.
Topics: Aged; Apolipoprotein A-I; Apolipoproteins; Delayed-Action Preparations; Depression, Chemical; Female; Humans; Immunoassay; Lipoproteins, HDL; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Time Factors; Uterine Neoplasms | 1984 |
In vitro functions of lymphocytes during high-dose medroxyprogesterone acetate (MPA) treatment.
Topics: Antibody Formation; B-Lymphocytes; Female; Humans; Leukocyte Count; Lymphocyte Activation; Lymphocytes; Medroxyprogesterone; Medroxyprogesterone Acetate; T-Lymphocytes; Uterine Neoplasms | 1984 |
[Cell surface changes after high-dosage progesterone treatment in endometrial carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron; Microscopy, Electron, Scanning; Microvilli; Middle Aged; Preoperative Care; Progesterone; Surface Properties; Uterine Neoplasms | 1984 |
Effect of progestogen (Depo-Provera) on annulate lamellae in endometrial carcinoma.
Topics: Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron; Neoplasms, Hormone-Dependent; Organoids; Uterine Neoplasms | 1984 |
[The importance of hormone receptor analysis for diagnosis and therapy of gynecologic malignancies].
Topics: Breast Neoplasms; Estrogen Antagonists; Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Progesterone; Receptors, Androgen; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms | 1983 |
Use of the progestogen challenge test to reduce the risk of endometrial cancer.
Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Progesterone; Prospective Studies; Risk; Uterine Neoplasms | 1980 |
Depo-Provera: a critical analysis.
Topics: Abnormalities, Drug-Induced; Animals; Breast Feeding; Contraceptive Agents, Female; Dogs; Female; Haplorhini; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Neoplasms; Pregnancy; United States; United States Food and Drug Administration; Uterine Neoplasms | 1980 |
[Clinical and histological studies of endometrial carcinoma of the uterus treated with medroxy-progesterone-acetate (author's transl)].
Topics: Adenocarcinoma; Adult; Aged; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms | 1980 |
[Changes of sex steroid hormone receptors in rat uterine cytosol during experimental induction of endometrial carcinoma (author's transl)].
Topics: Animals; Castration; Cytosol; Diethylstilbestrol; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Experimental; Rats; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid; Uterine Neoplasms; Uterus | 1981 |
Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
Topics: Adenocarcinoma; Endometrial Hyperplasia; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1981 |
Endometrial carcinoma insensitive to progestin and cytotoxic chemotherapy may respond to tamoxifen.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Tamoxifen; Uterine Neoplasms | 1981 |
Effect of hormone replacement therapy on bone and lipid metabolism in women oophorectomized for the treatment of gynecologic malignancies.
Topics: Adult; Bone and Bones; Bone Density; Cholesterol, HDL; Cholesterol, LDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Gonadal Steroid Hormones; Humans; Lipoproteins; Medroxyprogesterone Acetate; Ovarian Neoplasms; Ovariectomy; Premenopause; Uterine Neoplasms | 1994 |
Gene expression of epidermal growth factor in human endometrium during decidualization.
Topics: Blotting, Northern; Decidua; DNA Probes; Endometrium; Epidermal Growth Factor; Female; Gene Expression; Humans; In Situ Hybridization; Leiomyoma; Medroxyprogesterone Acetate; Pregnancy; Protein Precursors; RNA, Messenger; Uterine Neoplasms | 1994 |
Uterine papillary serous carcinoma in a 32-year-old with Turner's syndrome.
Topics: Adult; Cystadenocarcinoma, Papillary; Female; Humans; Medroxyprogesterone Acetate; Turner Syndrome; Uterine Neoplasms | 1994 |
Expression of connexin-43 in human myometrium and leiomyoma.
Topics: Adult; Cells, Cultured; Connexin 43; Estradiol; Female; Gap Junctions; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Muscle, Smooth; Myometrium; RNA, Messenger; Uterine Neoplasms | 1993 |
Uterine fibroids: protocols of integrated medical/surgical treatment.
Topics: Abortion, Habitual; Biopsy; Combined Modality Therapy; Estrogens, Conjugated (USP); Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Infertility, Female; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Pregnancy; Uterine Neoplasms; Uterus | 1993 |
Response of "benign" metastasizing leiomyoma to progestin withdrawal. Case report.
Topics: Female; Humans; Leiomyoma; Lung Neoplasms; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Progesterone Congeners; Uterine Neoplasms | 1993 |
[Endometrial carcinoma during estrogen replacement therapy in spite of addition of progestagens].
Topics: Adenocarcinoma; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms | 1993 |
Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
Topics: Adult; Amino Acid Sequence; Base Sequence; Cell Division; DNA; Estradiol; Female; Gene Expression; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone Acetate; Molecular Sequence Data; Muscle, Smooth; Myometrium; Receptors, LHRH; Transforming Growth Factor beta; Uterine Neoplasms | 1996 |
The effectiveness of medroxyprogesterone in the treatment of multiple metastasizing leiomyosarcomas: report of a case.
Topics: Antineoplastic Agents, Hormonal; Biopsy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hysterectomy; Leiomyosarcoma; Lung; Lung Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Thoracotomy; Uterine Neoplasms | 1996 |
Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study.
Topics: Antineoplastic Agents, Hormonal; Case-Control Studies; Female; Humans; Leiomyomatosis; Medroxyprogesterone Acetate; Multicenter Studies as Topic; Uterine Neoplasms | 1997 |
Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study.
Topics: Bone Density; Chemotherapy, Adjuvant; Delayed-Action Preparations; Drug Monitoring; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Progesterone Congeners; Uterine Neoplasms | 1997 |
Progestin-dependent stimulation of the human leukemia inhibitory factor promoter in SKUT-1B uterine tumor cells.
Topics: Female; Gene Expression Regulation, Neoplastic; Growth Inhibitors; Humans; Interleukin-6; Jurkat Cells; Leukemia Inhibitory Factor; Lymphokines; Medroxyprogesterone Acetate; Mifepristone; Progestins; Promoter Regions, Genetic; Receptors, Progesterone; RNA, Messenger; Sequence Deletion; Transfection; Tumor Cells, Cultured; Uterine Neoplasms | 1997 |
Effects of conjugated estrogens with or without medroxyprogesterone acetate on mammary carcinogenesis, uterine adenomyosis and femur in mice.
Topics: Adenoma; Animals; Antineoplastic Agents, Hormonal; Bone Density; Corpus Luteum; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Femur; Mammary Glands, Animal; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Mice; Progesterone; Prolactin; Thymidine Kinase; Thymidylate Synthase; Uterine Neoplasms; Uterus | 1997 |
Gynecology case challenge: vaginal bleeding in a woman taking an injectable contraceptive.
Topics: Adult; Contraceptive Agents, Female; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Polyps; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms; Uterus | 1998 |
Unsuspected uterine carcinosarcoma (heterologous) diagnosed following conservative therapies with medroxyprogesterone acetate for presumed early-stage endometrial carcinoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Carcinosarcoma; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Uterine Neoplasms | 2002 |
[Intrauterine pregnancy with uterine myoma after downregulation with GnRH analogs].
Topics: Adult; Antineoplastic Agents; Buserelin; Delayed-Action Preparations; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Complications, Neoplastic; Receptors, LHRH; Uterine Neoplasms | 1992 |
Determination of hormonal response in uterine cancer cell lines by the ATP bioluminescence assay and flow cytometry.
Topics: Adenocarcinoma; Adenosine Triphosphate; Antineoplastic Agents; Biological Assay; Female; Flow Cytometry; Humans; Luminescent Measurements; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured; Uterine Neoplasms | 1992 |
[The use of Provera (medroxyprogesterone acetate) for treating malignant tumors].
Topics: Adult; Aged; Breast Neoplasms; Combined Modality Therapy; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Medroxyprogesterone Acetate; Middle Aged; Tablets; Uterine Neoplasms | 1992 |
[Effect of high-dose medroxyprogesterone acetate on coagulative and fibrinolytic factors in patients with gynecological cancers].
Topics: Antithrombin III; Blood Coagulation; Blood Coagulation Factors; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Protein C; Uterine Neoplasms | 1992 |
Depo-Provera. Controversial contraceptive wins approval from FDA panel.
Topics: Adult; Breast Neoplasms; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Legislation, Drug; Medroxyprogesterone; Medroxyprogesterone Acetate; Osteoporosis; United States; United States Food and Drug Administration; Uterine Neoplasms | 1992 |
Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot study.
Topics: Adult; Antineoplastic Agents; Bone Density; Buserelin; Cholesterol; Contraceptive Agents, Female; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Pilot Projects; Triglycerides; Uterine Neoplasms | 1991 |
Mild and moderate endometriosis. Comparison of treatment modalities for infertile couples.
Topics: Adult; Antineoplastic Agents; Cautery; Danazol; Endometriosis; Female; Follow-Up Studies; Humans; Infertility, Female; Laparoscopy; Laparotomy; Laser Therapy; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Retrospective Studies; Uterine Neoplasms | 1991 |
The effects of Provera on chemotherapy of uterine cancer cell lines.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Progesterone; Tumor Cells, Cultured; Uterine Neoplasms | 1991 |
Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
Topics: Antineoplastic Agents; Female; Gene Expression Regulation, Neoplastic; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; RNA, Messenger; RNA, Neoplasm; Transforming Growth Factor alpha; Transforming Growth Factor beta; Tumor Cells, Cultured; Uterine Neoplasms | 1991 |
Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy: correlation with histology and steroid receptor content.
Topics: Adult; Antineoplastic Agents; Endometriosis; Female; Humans; Hysterectomy; Immunohistochemistry; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Ovariectomy; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1991 |
Treatment of abnormal uterine bleeding with the gynecologic resectoscope.
Topics: Adult; Aged; Amenorrhea; Antineoplastic Agents; Catheterization; Danazol; Electrocoagulation; Endometrium; Female; Humans; Hysteroscopes; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Uterine Neoplasms; Uterus | 1991 |
[Growth regulation of sex steroid hormone in endometrial carcinoma transplanted into nude mice].
Topics: Adenocarcinoma; Animals; Cell Division; Endometriosis; Estradiol; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured; Uterine Neoplasms | 1991 |
Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy.
Topics: Drug Therapy, Combination; Endometriosis; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Uterine Neoplasms | 1990 |
[Effect of medroxyprogesterone acetate on cerebral blood flow].
Topics: Antineoplastic Agents; Cerebrovascular Circulation; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Tomography, Emission-Computed, Single-Photon; Uterine Neoplasms | 1990 |
Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Papillary; Carcinoma, Squamous Cell; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Multivariate Analysis; Neoplasm Invasiveness; Receptors, Estrogen; Receptors, Progesterone; Sarcoma; Survival Analysis; Uterine Neoplasms | 1990 |
Medroxyprogesterone acetate binding sites in human endometrium and endometrial cancer.
Topics: Binding Sites; Centrifugation, Density Gradient; Endometrium; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Progesterone; Uterine Neoplasms | 1990 |
Hormone receptors and enzymatic activities in human endometrial adenocarcinoma.
Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Cell Nucleus; Creatine Kinase; Cytosol; Endometrium; Female; Humans; Interferon Type I; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured; Uterine Neoplasms | 1990 |
The histochemistry of oestradiol-17 beta dehydrogenase in normal endometrium and endometrial carcinoma: a test to predict the sensitivity of endometrial carcinoma to progestogens: a preliminary report.
Topics: 17-Hydroxysteroid Dehydrogenases; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Uterine Neoplasms | 1990 |
[A case of marked effectiveness using medroxyprogesterone acetate (MPA) in lung metastases of cancer of the uterine body].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Remission Induction; Uterine Neoplasms | 1990 |
[Progestins in combined treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Progestins; Uterine Neoplasms | 1990 |
Comparison of mass spectrometry and radioimmunoassay to measure medroxyprogesterone acetate in patients with endometrial cancer.
Topics: Aged; Antineoplastic Agents; Female; Gas Chromatography-Mass Spectrometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Radioimmunoassay; Time Factors; Uterine Neoplasms | 1990 |
Medroxyprogesterone acetate in non-metastatic gestational trophoblastic disease.
Topics: Adolescent; Adult; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Peptide Fragments; Pregnancy; Prospective Studies; Recurrence; Trophoblastic Neoplasms; Uterine Neoplasms | 1987 |
[Diagnosis and treatment of endometrial hyperplasia].
Topics: ABO Blood-Group System; Adenocarcinoma; DNA Polymerase II; Endometrial Hyperplasia; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Oncogenes; Protein Biosynthesis; Receptors, Estrogen; Uterine Neoplasms | 1989 |
Estrone sulfatase activity in normal and neoplastic endometrial tissues of human uterus.
Topics: Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Progesterone; Sulfatases; Uterine Neoplasms | 1989 |
Effect of medroxyprogesterone acetate on secondary spreading of endometrial cancer.
Topics: Angiogenesis Inducing Agents; Animals; Antineoplastic Agents; Basement Membrane; Cell Adhesion; Cell Line; Cells, Cultured; Female; Fibroblast Growth Factors; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Tumor Cells, Cultured; Uterine Neoplasms | 1989 |
[Effect of medroxyprogesterone acetate on side effects of CAP therapy in gynecological malignant tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Humans; Leukocyte Count; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Platelet Count; Uterine Neoplasms | 1989 |
[Combination with medroxyprogesterone acetate and chemotherapy making possible complete removal of uterine corpus carcinoma].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Remission Induction; Reoperation; Uterine Neoplasms | 1989 |
Estrogen biosynthesis in human uterine adenomyosis.
Topics: Adult; Aromatase; Cells, Cultured; Danazol; Endometriosis; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Progesterone; Uterine Neoplasms | 1989 |
[Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Receptors, Progesterone; Uterine Neoplasms | 1989 |
Treatment of advanced endometrial adenocarcinoma with cyclic sequential ethinyl estradiol and medroxyprogesterone acetate.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Thrombophlebitis; Uterine Neoplasms | 1989 |
Mechanism of antitumoral activity of medroxyprogesterone acetate for endometrial cancer.
Topics: Antineoplastic Agents; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mifepristone; Norethindrone; Receptors, Progesterone; Tumor Cells, Cultured; Tumor Stem Cell Assay; Uterine Neoplasms | 1989 |
Treatment of advanced and recurrent endometrial carcinoma: correlation of patient response to hormonal and cytotoxic chemotherapy and the response predicted by the subrenal capsule chemosensitivity assay.
Topics: Actuarial Analysis; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Evaluation Studies as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Subrenal Capsule Assay; Uterine Neoplasms | 1989 |
Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: a pilot study.
Topics: Bone and Bones; Climacteric; Drug Administration Schedule; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pilot Projects; Ultrasonography; Uterine Neoplasms; Uterus | 1989 |
Endolymphatic stromal myosis: surgical and hormonal therapy for extensive venous recurrence.
Topics: Adult; Antineoplastic Agents; Combined Modality Therapy; Delayed-Action Preparations; Estrogens, Conjugated (USP); Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Pelvic Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Renal Veins; Sarcoma; Uterine Neoplasms; Vena Cava, Inferior | 1989 |
[Effect of progestin therapy on the level of cytoplasmic receptors in patients with cancer of the corpus uteri].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents; Cytoplasm; Drug Evaluation; Female; Homeostasis; Humans; Hydroxyprogesterones; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Preoperative Care; Receptors, Cell Surface; Reproduction; Uterine Neoplasms; Vaginal Smears | 1989 |
Cytochemical examinations of Ca, cytochrome oxidase and succinate dehydrogenase enzymes in endometrium carcinomatous tissue after high dose progestogen treatment.
Topics: Antineoplastic Agents; Calcium; Electron Transport Complex IV; Female; Histocytochemistry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron; Mitochondria; Succinate Dehydrogenase; Uterine Neoplasms | 1988 |
High-dose depot-medroxyprogesterone acetate--effects on the fatty acid composition of serum lecithin and cholesterol ester.
Topics: 8,11,14-Eicosatrienoic Acid; Aged; Arachidonic Acid; Arachidonic Acids; Cholesterol Esters; Fatty Acids; Female; Humans; Linoleic Acid; Linoleic Acids; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Palmitic Acids; Phosphatidylcholines; Stearic Acids; Uterine Neoplasms | 1985 |
[Effect of long-term high-dose progesterone (Depo-Provera) therapy on endometrial carcinoma].
Topics: Aged; Carcinoma; Combined Modality Therapy; Dose-Response Relationship, Drug; Endometrial Hyperplasia; Endometrium; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron, Scanning; Preoperative Care; Uterine Neoplasms | 1985 |
The effects of medroxyprogesterone acetate on enzyme activities in human endometrial carcinoma.
Topics: Creatine Kinase; Cytosol; Enzyme Activation; Female; Glucosephosphate Dehydrogenase; Humans; Isocitrate Dehydrogenase; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1985 |
Modalities and results of a combined anti-estrogenic therapy by means of tamoxifen and medroxyprogesterone in gynecologic cancerology.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Hemorrhage; Uterine Neoplasms | 1986 |
Effects of estradiol on deoxyribonucleic acid polymerase alpha activity in the Ishikawa human endometrial adenocarcinoma cell line.
Topics: Adenocarcinoma; Cell Line; DNA Polymerase II; Enzyme Activation; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Tamoxifen; Uterine Neoplasms | 1986 |
Endocrine aspects of human uterine sarcoma: a preliminary study.
Topics: Adult; Aged; Aminoglutethimide; Animals; Aromatase; Aromatase Inhibitors; Cells, Cultured; Estradiol; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Middle Aged; Nandrolone; Neoplasm Transplantation; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Sarcoma; Uterine Neoplasms | 1986 |
Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
Topics: Aged; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Myometrium; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1986 |
The status of receptors in the management of endometrial cancer.
Topics: Antineoplastic Agents; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Neoplasm Staging; Progesterone; Prognosis; Receptors, Progesterone; Uterine Neoplasms | 1986 |
Isolated abdominal wound recurrence of an endometrial adenocarcinoma confined to a polyp.
Topics: Abdominal Neoplasms; Adenocarcinoma; Combined Modality Therapy; Electrons; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Seeding; Ovariectomy; Polyps; Time Factors; Uterine Neoplasms | 1986 |
[Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
Topics: Adenocarcinoma; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1986 |
[Therapy with gestagens in hyperplastic changes of the endometrium].
Topics: Adenocarcinoma; Adenoma; Endometrial Hyperplasia; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norethindrone Acetate; Uterine Neoplasms | 1986 |
Steroid receptors and response of endometrial cancer to hormones in vitro.
Topics: Adenocarcinoma; Adenosine Triphosphate; Drug Combinations; Drug Screening Assays, Antitumor; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Progesterone; Receptors, Steroid; Tamoxifen; Tumor Cells, Cultured; Uterine Neoplasms | 1987 |
[Hormone therapy--recent advances].
Topics: Breast Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptors, Androgen; Receptors, Estrogen; Tamoxifen; Uterine Neoplasms | 1987 |
[Hormone dependency and progestogen therapy in the treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cell Division; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Norethindrone; Tamoxifen; Tumor Stem Cell Assay; Uterine Neoplasms | 1987 |
[Studies on estradiol dehydrogenase activity in the human uterine endometrium].
Topics: 17-Hydroxysteroid Dehydrogenases; Dose-Response Relationship, Drug; Endometrium; Estradiol Dehydrogenases; Female; Hormones; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Progestins; Uterine Neoplasms | 1987 |
Nude mouse system in the study of tumor biology, treatment strategies and progesterone receptor physiology in human endometrial carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Differentiation; Estradiol; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Transplantation, Heterologous; Uterine Neoplasms | 1987 |
Continuous, high-dose progestogen treatment of endometrial cancer.
Topics: Aged; Aged, 80 and over; Carcinoma; Combined Modality Therapy; Dose-Response Relationship, Drug; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron, Scanning; Uterine Neoplasms | 1987 |
[A case of stromal endometriosis (endolymphatic stromal myosis) in the effective treatment with progestogen].
Topics: Adult; Endometriosis; Female; Humans; Hysterectomy; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Pneumonectomy; Uterine Neoplasms | 1988 |
Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
Topics: Adenocarcinoma; Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Female; Humans; Injections, Intramuscular; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Neoplasm Metastasis; Prognosis; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1988 |
In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Line; Depression, Chemical; Drug Evaluation; Drug Evaluation, Preclinical; Drug Synergism; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Postoperative Care; Receptors, Steroid; Tamoxifen; Tumor Cells, Cultured; Uterine Neoplasms | 1988 |
[Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action].
Topics: Estrenes; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Mifepristone; Neoplasms, Hormone-Dependent; Norethindrone; Norgestrel; Progesterone Congeners; Receptors, Progesterone; Tumor Stem Cell Assay; Uterine Neoplasms | 1988 |
Inhibitory effects of danazol and medroxyprogesterone acetate on [3H]thymidine incorporation in human endometrial cancer cells.
Topics: Adenocarcinoma; Adult; Aged; Cell Division; Danazol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Receptors, Progesterone; Thymidine; Tumor Cells, Cultured; Uterine Neoplasms | 1988 |
Progestin regulation of protein synthesis in endometrial cancer.
Topics: Cells, Cultured; Creatine Kinase; Electrophoresis, Polyacrylamide Gel; Female; Humans; Isoelectric Focusing; Isoelectric Point; Medroxyprogesterone; Medroxyprogesterone Acetate; Molecular Weight; Organ Culture Techniques; Progesterone; Progestins; Protein Biosynthesis; Tubulin; Uterine Neoplasms | 1988 |
[Characteristics of the surgical stage in the combined treatment of poorly differentiated cancer of the corpus uteri].
Topics: Adenocarcinoma; Brachytherapy; Combined Modality Therapy; Female; Humans; Hysterectomy; Lymph Node Excision; Medroxyprogesterone; Medroxyprogesterone Acetate; Mesonephroma; Postoperative Care; Preoperative Care; Radiotherapy Dosage; Time Factors; Uterine Neoplasms | 1988 |
[Adjuvant gestagen therapy in stage I endometrial cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Uterine Neoplasms | 1988 |
Medroxyprogesterone acetate enhances spontaneous mammary tumorigenesis and uterine adenomyosis in mice.
Topics: Animals; Cell Transformation, Neoplastic; Endometriosis; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Organ Size; Precancerous Conditions; Uterine Neoplasms | 1988 |
[Experimental study of the treatment of uterine leiomyosarcoma in the mouse with progestogen].
Topics: Animals; Female; Leiomyosarcoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Rats; Rats, Inbred Strains; Receptors, Estrogen; Uterine Neoplasms | 1988 |
Immunohistological localization of pregnancy-associated endometrial alpha 2-globulin (alpha 2-PEG) in endometrial adenocarcinoma and effect of medroxyprogesterone acetate.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Endometrium; Female; Glycodelin; Glycoproteins; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pregnancy Proteins; Uterine Neoplasms | 1988 |
Hormonal receptors in endometrial neoplasias.
Topics: Endometrial Hyperplasia; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Receptors, Estradiol; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms | 1988 |
Persistence of endometrial activity after radiation therapy for cervical carcinoma.
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Dilatation and Curettage; Endometrium; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Hyperplasia; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovariectomy; Radiotherapy; Radiotherapy Dosage; Risk; Uterine Cervical Neoplasms; Uterine Hemorrhage; Uterine Neoplasms | 1985 |
Effects of high dose progestin on serum lipids and lipid metabolizing enzymes in patients with endometrial cancer.
Topics: Adipose Tissue; Adult; Aged; Cholesterol; Cholesterol, HDL; Female; Humans; Lipids; Lipoprotein Lipase; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Phosphatidylcholine-Sterol O-Acyltransferase; Triglycerides; Uterine Neoplasms | 1985 |
Short-term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17 beta-hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinoma.
Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Adult; Aged; Cell Nucleus; Cytosol; Danazol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron; Middle Aged; Pregnadienes; Receptors, Estrogen; Receptors, Progesterone; Temperature; Time Factors; Uterine Neoplasms | 1985 |
Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate.
Topics: Adenocarcinoma; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Uterine Neoplasms | 1985 |
Plasminogen activator activity in human endometrial carcinoma.
Topics: Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Plasminogen Activators; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1985 |
[Flow cytometric study on the action of progestogen in patients with adenocarcinoma and precancerous lesions of the endometrium].
Topics: Adenocarcinoma; Adult; Aged; Cell Cycle; DNA, Neoplasm; Female; Flow Cytometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Precancerous Conditions; RNA, Neoplasm; Software; Uterine Neoplasms | 1985 |
[Effects of long-term high doses of sex steroid hormones on human endometrial adenocarcinoma transplanted into nude mice].
Topics: Adenocarcinoma, Papillary; Animals; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Uterine Neoplasms | 1985 |